Evidence map›Paper›PMID 39291199›Full record

ArticleKidney international reports2024

Exploring Apixaban Pharmacokinetics, Pharmacodynamics, and Safety in Hemodiafiltration Patients.

Aurema Otero, Elena Rosselló-Palmer, Sergi Codina, Nuria Lloberas, Yurema Martínez, Naiara Santos, Judith Peñafiel, Raúl Rigo-Bonnin, Anna Vidal, Joan Peris and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Aurema OteroClinical Research Support Unit, Clinical Pharmacology Department, Hospital Universitari Bellvitge, L'Hospitalet del Llobregat, Spain.
Elena Rosselló-PalmerThrombosis and Haemostasis Unit, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Spain.
Sergi CodinaDepartment of Nephrology, Hospital Universitari de Bellvitge, Nephrology and Renal Transplantation Group, Infectious Disease and Transplantation Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
Nuria LloberasExperimental Nephrology and Transplantation Laboratory, Nephrology and Renal Transplantation Group, Infectious Disease and Transplantation Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
Yurema MartínezClinical Research Support Unit, Clinical Pharmacology Department, Hospital Universitari Bellvitge, L'Hospitalet del Llobregat, Spain.
Naiara SantosBiostatistics Unit, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
Judith PeñafielBiostatistics Unit, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
Raúl Rigo-BonninClinical Laboratory Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
Anna VidalExperimental Nephrology and Transplantation Laboratory, Nephrology and Renal Transplantation Group, Infectious Disease and Transplantation Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
Joan PerisThrombosis and Haemostasis Unit, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Spain.
Sebastià VidelaClinical Research Support Unit, Clinical Pharmacology Department, Hospital Universitari Bellvitge, L'Hospitalet del Llobregat, Spain.
Miguel HuesoDepartment of Nephrology, Hospital Universitari de Bellvitge, Nephrology and Renal Transplantation Group, Infectious Disease and Transplantation Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

apixabandialysishemodiafiltrationpharmacodynamicspharmacokinetics

Identifiers

PMID39291199
PMCPMC11403021

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.